CIK 0001360214
- Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450567010
- Phone
- +1 615-733-4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 4 Open-market buy Director bought 25,000 shares at $13.37 ($334,250)
- 4 Open-market buy Director bought 1,860 shares at $13.42 ($24,961)
- 4 Open-market buy 10% owner bought 431,183 shares at $10.52 ($4,536,045)
- 4 Open-market sale Director sold 40,000 shares at $12.62 ($504,800)
- 4 Open-market buy 10% owner bought 11,085 shares at $9.77 ($108,354)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 41,389 shares at an average $6.75 ($279,502)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Financial Officer gave up 20,605 shares (to pay taxes)
- 4 Shares withheld for taxes President, ImprimisRx gave up 25,923 shares (to pay taxes)
- 4 Open-market buy 10% owner bought 6,343 shares at $6.89 ($43,686)
- 4 Shares withheld for taxes Chief Executive Officer gave up 71,406 shares (to pay taxes)
- 4 Open-market sale Director sold 3,900 shares at $10.04 ($39,156)
- 4 Open-market sale Director sold 20,000 shares at an average $9.07 ($181,391)
- 4 Open-market buy 10% owner bought 52,500 shares at $8.45 ($443,363)
Page 5 of 15 · 296 filings